CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/03/2023
Back to search
Official data from USPTO
PATIENT CONNECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
03/03/2023
Trademark type
Combined
Nice classes
44
Filing date
04/21/2020
Registration date
06/14/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/14/2022
Last transaction
06/14/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2012-01-00
First use in commerce
2012-01-00
Drawing code
3
Owner type
03
Owner location
Paris, FR
Examiner
INGRAM, KYLE G
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "PATIENT CONNECTION". The words "PATIENT" and "CONNECTION" are linked by a series of dots that form two arcs. The first arc curves upward between the "I" in "PATIENT" and the first "O" in "CONNECTION". The second arc curves downward between the first "O" and second "O" in "CONNECTION".
Holders and representatives
Holders
Sanofi
Representatives
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Healthcare serviceswellness programs; dispensing of pharmaceuticals for underserved populations; providing medical information and educational information in the field of healthcare
Publications
History of USPTO decisions and trademark events.
37 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/03/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/14/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/14/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
05/08/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/28/2021
PUBO
PUBLISHED FOR OPPOSITION
12/28/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/19/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/19/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/19/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/19/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/19/2021
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
05/04/2021
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
05/04/2021
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
05/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/21/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/20/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/20/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/03/2021
GNFR
FINAL REFUSAL E-MAILED
02/03/2021
CNFR
FINAL REFUSAL WRITTEN
02/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2021
ALIE
ASSIGNED TO LIE
01/31/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/21/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/02/2020
GNRT
NON-FINAL ACTION E-MAILED
06/02/2020
CNRT
NON-FINAL ACTION WRITTEN
06/02/2020
DOCK
ASSIGNED TO EXAMINER
05/28/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/30/2020
NWAP
NEW APPLICATION ENTERED
04/24/2020
Continuous trademark protection
Get notified about every new filing that threatens PATIENT CONNECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.